Peer Review reports
From: Remifentanil but not sufentanil induces cardioprotection in human ischemic heart muscle in vitro
| Original Submission | ||
|---|---|---|
| 18 May 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| 6 Dec 2022 | Reviewed | Reviewer Report |
| 14 Dec 2022 | Reviewed | Reviewer Report |
| 11 Jan 2023 | Author responded | Author comments - Wojciech Płazak |
| Resubmission - Version 5 | ||
| 11 Jan 2023 | Submitted | Manuscript version 5 |
| 31 Jan 2023 | Reviewed | Reviewer Report |
| 1 Feb 2023 | Reviewed | Reviewer Report |
| 12 Feb 2023 | Author responded | Author comments - Wojciech Płazak |
| Resubmission - Version 6 | ||
| 12 Feb 2023 | Submitted | Manuscript version 6 |
| 1 Mar 2023 | Reviewed | Reviewer Report |
| 5 Mar 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 7 Mar 2023 | Editorially accepted | |
| 20 Apr 2023 | Article published | 10.1186/s40360-023-00660-3 |
You can find further information about peer review here.